PATH-07. QUALITY ASSURANCE IN CEREBROSPINAL FLUID CYTOLOGY ASSESSMENT FOR MEDULLOBLASTOMA STAGING LEADS TO POTENTIAL IMPROVED RISK-GROUP ASSESSMENT IN THE PROSPECTIVE MULTICENTER HIT-2000 TRIAL

Authors: Christian Hagel, Veronika Sloman, Martin Mynarek, Katharina Petrasch, Denise Obrecht, Frank Deinlein, Renate Schmid, André O von Bueren, Carsten Friedrich, B Ole Juhnke, Nicolas U Gerber, Robert Kwiecien, Hermann Girschick, Alexandra Höller, Antonia Zapf, Katja von Hoff, Stefan Rutkowski

Published: 2020-12-04

DOI: 10.1093/neuonc/noaa222.643

Source: Full article

PATH-07. QUALITY ASSURANCE IN CEREBROSPINAL FLUID CYTOLOGY ASSESSMENT FOR MEDULLOBLASTOMA STAGING LEADS TO POTENTIAL IMPROVED RISK-GROUP ASSESSMENT IN THE PROSPECTIVE MULTICENTER HIT-2000 TRIAL

Abstract